BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6575702)

  • 1. The biosynthesis of fibrinogen: in vivo studies.
    Bell WR
    Ann N Y Acad Sci; 1983 Jun; 408():503-20. PubMed ID: 6575702
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products.
    Kessler CM; Bell WR
    Blood; 1980 Jan; 55(1):40-7. PubMed ID: 7350940
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin-specific fibrinolysis.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1992 Dec; 667():259-71. PubMed ID: 1285022
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
    Ishida T; Tanaka K
    Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha 2-plasmin inhibitor deficiency.
    Lipinski B; Gurewich V
    Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen.
    Alving BM; Bell WR; Evatt BL
    Am J Physiol; 1977 May; 232(5):H478-84. PubMed ID: 860765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
    Gurewich V; Pannell R; Louie S; Kelley P; Suddith RL; Greenlee R
    J Clin Invest; 1984 Jun; 73(6):1731-9. PubMed ID: 6725557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fibrin degradation products and thrombin on fibrinogen synthesis.
    Ittyerah TR; Weidner N; Wochner RD; Sherman LA
    Br J Haematol; 1979 Dec; 43(4):661-8. PubMed ID: 526446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of fibrinogen synthesis by thrombin in rabbits with ancrod-induced afibrinogenemia.
    Alving BM; Evatt BL; Bell WR
    Am J Physiol; 1977 Nov; 233(5):562-7. PubMed ID: 920833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G; Popov S; Wolf H; Welzel D
    Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis.
    Ge M; Tang G; Ryan TJ; Malik AB
    J Clin Invest; 1992 Dec; 90(6):2508-16. PubMed ID: 1281836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
    Van Leer C; Stutz M; Haeberli A; Geiser T
    Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.